Safety and Efficacy of Second Infusion of Autologous Immunosuppressive CAR-DC Targeting FAP in the Treatment of End-stage Dilated Cardiomyopathy
NCT07516288 · NOT YET RECRUITING · Phase 1
We track 5 ClinicalTrials.gov studies led by Second Affiliated Hospital School Of Medicine Zhejiang University. The portfolio skews toward Phase 1 (3 trials).
5 clinical trials sponsored by Second Affiliated Hospital School Of Medicine Zhejiang University.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 3 | 60% |
| Phase 3 | 1 | 20% |
| Phase 2 | 1 | 20% |
Second Affiliated Hospital School Of Medicine Zhejiang University currently sponsors 5 clinical trials tracked on ReadTheTrial. These span Phase 1, Phase 3, Phase 2.
Second Affiliated Hospital School Of Medicine Zhejiang University conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Second Affiliated Hospital School Of Medicine Zhejiang University currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.